The Darkside of Tox

@NEVERTOX on Instagram is our #1 social media site! Please be sure to follow along with us there. We are extremely proud of how our page has grown! In June of 2023, we hit just over 20k followers. In December of 2024 we hit 100k followers!

 Our goal is to find people who have yet to learn about the dark side of botulinum toxin products. But, we can't do it alone and that is where you come in! Our posts are designed to be loved, commented on, shared to your stories, saved or sent directly to a friend who might be considering cosmetic or medical Botox, Dysport, Xeomin, Jeuveau or Daxxify. Then, we invite you to work alongside of us to help people make a more informed decision regarding botulinum toxin injections. We love our Never Tox community, and know you will too.

We are big supporters in return of other accounts who share our content! 

We believe that everyone has an amazing story to tell.

See you on the GRAM! 

 

Attribution Required & Content Use Policy:

​

All content shared on this platform, including text, images, videos, and graphics is the original work of Never Tox: The Dark Side of Tox, unless otherwise stated. Certain materials featured on the Never Tox page were created exclusively for Never Tox’s use, and full rights to this content are owned by Never Tox.

 

We welcome thoughtful engagement and sharing of our work, but ask that the following terms be respected:

 

• Written permission is required before any content is copied, reproduced, or republished in full or in part.

• When referencing or reposting our work on social media, proper credit and visible tagging of @Nevertox are required.

• Content may not be altered, edited, or presented in a way that changes its original meaning, message, or context.

• Commercial, editorial, or media use of our materials requires a separate written agreement.

• For collaboration, citation, or media requests, please contact us directly at hi.nevertox@gmail.com

 

Proper attribution is essential not only to protect original work, but also to maintain the accuracy and integrity of information related to iatrogenic botulism, botulinum neurotoxin mechanisms, and associated health risks. Responsible sharing reduces misinformation and supports our commitment to patient safety, transparency, and informed consent.